These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 28752465)
21. Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature. Parr DG; Lara B Drug Des Devel Ther; 2017; 11():2149-2162. PubMed ID: 28769553 [TBL] [Abstract][Full Text] [Related]
22. A review of augmentation therapy for alpha-1 antitrypsin deficiency. Mohanka M; Khemasuwan D; Stoller JK Expert Opin Biol Ther; 2012 Jun; 12(6):685-700. PubMed ID: 22500781 [TBL] [Abstract][Full Text] [Related]
23. Results of a survey of patients with alpha-1 antitrypsin deficiency. Strange C; Stoller JK; Sandhaus RA; Dickson R; Turino G Respiration; 2006; 73(2):185-90. PubMed ID: 16141711 [TBL] [Abstract][Full Text] [Related]
24. Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies. Tonelli AR; Brantly ML Ther Adv Respir Dis; 2010 Oct; 4(5):289-312. PubMed ID: 20650978 [TBL] [Abstract][Full Text] [Related]
25. A review of α1-antitrypsin deficiency. Stoller JK; Aboussouan LS Am J Respir Crit Care Med; 2012 Feb; 185(3):246-59. PubMed ID: 21960536 [TBL] [Abstract][Full Text] [Related]
26. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE). McElvaney NG; Burdon J; Holmes M; Glanville A; Wark PA; Thompson PJ; Hernandez P; Chlumsky J; Teschler H; Ficker JH; Seersholm N; Altraja A; Mäkitaro R; Chorostowska-Wynimko J; Sanak M; Stoicescu PI; Piitulainen E; Vit O; Wencker M; Tortorici MA; Fries M; Edelman JM; Chapman KR; Lancet Respir Med; 2017 Jan; 5(1):51-60. PubMed ID: 27916480 [TBL] [Abstract][Full Text] [Related]
27. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin]. Wencker M; Banik N; Buhl R; Seidel R; Konietzko N Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632 [TBL] [Abstract][Full Text] [Related]
32. [Longterm Homecare Augmentation Program in Alpha-1-Antitrypsin Deficient Patients]. Wilke A; Semper H; Gross C; Grohé C Pneumologie; 2018 Aug; 72(8):590-597. PubMed ID: 30089330 [TBL] [Abstract][Full Text] [Related]
33. Long-term augmentation therapy in twenty patients with severe alpha-1-antitrypsin deficiency--three-year follow-up. Schwaiblmair M; Vogelmeier C; Fruhmann G Respiration; 1997; 64(1):10-5. PubMed ID: 9044469 [TBL] [Abstract][Full Text] [Related]
34. Trials and Tribulations: An Industry Perspective on Conducting Registrational Trials in Alpha-1 Antitrypsin Deficiency. Forshag MS Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S374-7. PubMed ID: 27564675 [TBL] [Abstract][Full Text] [Related]
35. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Abboud RT; Vimalanathan S Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259 [TBL] [Abstract][Full Text] [Related]
36. Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use. Karnaukhova E; Ophir Y; Golding B Amino Acids; 2006 Jun; 30(4):317-32. PubMed ID: 16773239 [TBL] [Abstract][Full Text] [Related]